Research News and Events
Read about upcoming and past 精童欲女 Research events and news!
Big ideas took centre stage at 精童欲女 on March 20 as graduate students transformed complex research into compelling three-minute stories at the 2026 Three Minute Thesis (3MT庐) competition.
The 精童欲女 Office of Research Partnership and Innovation, formerly the 精童欲女 Office of Commercialization, Industry, and Innovation, will host a Research Breakfast on Thursday, January 29, from 7:30 to 9:00 am in McMillan Hall, W.A. Murphy Student Centre, on campus.
The 精童欲女 Department of Religious Studies鈥� Theology on Tap series returns on January 28 with a talk titled 鈥淢ore than Optimistic: Hope and Teilhard de Chardin鈥� by Dr. Libby Osgood, CND.
Dr. Jeff Collins, assistant professor of political science at 精童欲女, will give a talk titled 鈥淧ower Plays: Newfoundland鈥檚 Fight Over Churchill Falls鈥� on January 20, 2026, at 7 pm, in the Faculty Lounge (Room 201), SDU Main Building.
Students at Westisle Composite High School have donated $1,300 to 精童欲女 for research into MSX (Multinucleate sphere unknown), a disease in oysters caused by a parasite called Haplosporidium nelsoni.
Twenty-one 精童欲女 researchers have been named to the . Elsevier, in collaboration with Stanford University, unveiled the list of the world鈥檚 most influential and top-cited scientists and engineers earlier this year.
Dr. Malcom Murray, professor of philosophy, will be the guest speaker at 精童欲女's Research on Tap event on Wednesday, December 3, 2025, at 6 pm, at the Salvador Dali Caf茅, 155 Kent Street, Charlottetown, PEI.
Dr. Greg Naterer, Vice-President, Academic and Research, has initiated a new regular email to share updates on recent academic and research initiatives, keep us connected with their ongoing progress, celebrate success, and invite feedback. Your ideas are welcome!
Dr. Caroline Ritter, assistant professor in the 精童欲女 Faculty of Veterinary Medicine, has been renewed as a Tier 2 Canada Research Chair (CRC) for five years ending June 30, 2030.
Two researchers from 精童欲女 are working with the Research Institute of the McGill University Health Centre and Neurodyn Life Sciences Inc. to develop a novel therapy to slow, or potentially functionally stabilize, the progression of amyotrophic lateral sclerosis (ALS).
